90 related articles for article (PubMed ID: 20226001)
1. Biochemical characterization and NMR study of the region E748-A785 of the human protein MRP6/ABCC6.
Ostuni A; Miglionico R; Bisaccia F; Castiglione Morelli MA
Protein Pept Lett; 2010 Jul; 17(7):861-6. PubMed ID: 20226001
[TBL] [Abstract][Full Text] [Related]
2. Study of the nucleotide-binding domain 1 of the human transporter protein MRP6.
Ostuni A; Miglionico R; Castiglione Morelli MA; Bisaccia F
Protein Pept Lett; 2010 Dec; 17(12):1553-8. PubMed ID: 20858202
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization and NMR studies of the nucleotide-binding domain 1 of multidrug-resistance-associated protein 1: evidence for interaction between ATP and Trp653.
Ramaen O; Masscheleyn S; Duffieux F; Pamlard O; Oberkampf M; Lallemand JY; Stoven V; Jacquet E
Biochem J; 2003 Dec; 376(Pt 3):749-56. PubMed ID: 12954082
[TBL] [Abstract][Full Text] [Related]
4. The nucleotide-binding domain 2 of the human transporter protein MRP6.
Ostuni A; Miglionico R; Monné M; Castiglione Morelli MA; Bisaccia F
J Bioenerg Biomembr; 2011 Oct; 43(5):465-71. PubMed ID: 21748403
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6).
Cai J; Daoud R; Alqawi O; Georges E; Pelletier J; Gros P
Biochemistry; 2002 Jun; 41(25):8058-67. PubMed ID: 12069597
[TBL] [Abstract][Full Text] [Related]
6. ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum.
Hu X; Plomp A; Wijnholds J; Ten Brink J; van Soest S; van den Born LI; Leys A; Peek R; de Jong PT; Bergen AA
Eur J Hum Genet; 2003 Mar; 11(3):215-24. PubMed ID: 12673275
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis reveals pathomechanisms associated with pseudoxanthoma elasticum-causing mutations in the ABCC6 transporter.
Ran Y; Zheng A; Thibodeau PH
J Biol Chem; 2018 Oct; 293(41):15855-15866. PubMed ID: 30154241
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of the L0 cytoplasmic loop of human multidrug resistance protein 6 (MRP6).
Ostuni A; Castiglione Morelli MA; Cuviello F; Bavoso A; Bisaccia F
Biochim Biophys Acta Biomembr; 2019 Feb; 1861(2):380-386. PubMed ID: 30423326
[TBL] [Abstract][Full Text] [Related]
9. Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1).
Payen LF; Gao M; Westlake CJ; Cole SP; Deeley RG
J Biol Chem; 2003 Oct; 278(40):38537-47. PubMed ID: 12882957
[TBL] [Abstract][Full Text] [Related]
10. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6).
Iliás A; Urbán Z; Seidl TL; Le Saux O; Sinkó E; Boyd CD; Sarkadi B; Váradi A
J Biol Chem; 2002 May; 277(19):16860-7. PubMed ID: 11880368
[TBL] [Abstract][Full Text] [Related]
11. Clustering of disease-causing mutations on the domain-domain interfaces of ABCC6.
Fülöp K; Barna L; Symmons O; Závodszky P; Váradi A
Biochem Biophys Res Commun; 2009 Feb; 379(3):706-9. PubMed ID: 19133228
[TBL] [Abstract][Full Text] [Related]
12. Membrane insertion and topology of the amino-terminal domain TMD0 of multidrug-resistance associated protein 6 (MRP6).
Cuviello F; Tellgren-Roth Å; Lara P; Ruud Selin F; Monné M; Bisaccia F; Nilsson I; Ostuni A
FEBS Lett; 2015 Dec; 589(24 Pt B):3921-8. PubMed ID: 26545497
[TBL] [Abstract][Full Text] [Related]
13. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
Buyse F; Hou YX; Vigano C; Zhao Q; Ruysschaert JM; Chang XB
Biochem J; 2006 Jul; 397(1):121-30. PubMed ID: 16551273
[TBL] [Abstract][Full Text] [Related]
14. Attempts to characterize the NBD heterodimer of MRP1: transient complex formation involves Gly771 of the ABC signature sequence but does not enhance the intrinsic ATPase activity.
Ramaen O; Sizun C; Pamlard O; Jacquet E; Lallemand JY
Biochem J; 2005 Nov; 391(Pt 3):481-90. PubMed ID: 16014004
[TBL] [Abstract][Full Text] [Related]
15. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.
Chassaing N; Martin L; Calvas P; Le Bert M; Hovnanian A
J Med Genet; 2005 Dec; 42(12):881-92. PubMed ID: 15894595
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of Nucleotide Binding Domain Dimers Rescues ABCC6 Mutants Associated with Pseudoxanthoma Elasticum.
Ran Y; Thibodeau PH
J Biol Chem; 2017 Feb; 292(5):1559-1572. PubMed ID: 27994049
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic Analysis of the Putative ABCC6 Substrate-Binding Cavity Using a New Homology Model.
Szeri F; Corradi V; Niaziorimi F; Donnelly S; Conseil G; Cole SPC; Tieleman DP; van de Wetering K
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199119
[TBL] [Abstract][Full Text] [Related]
18. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter.
Ringpfeil F; Lebwohl MG; Christiano AM; Uitto J
Proc Natl Acad Sci U S A; 2000 May; 97(11):6001-6. PubMed ID: 10811882
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE).
Schulz V; Hendig D; Henjakovic M; Szliska C; Kleesiek K; Götting C
Hum Mutat; 2006 Aug; 27(8):831. PubMed ID: 16835894
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients.
Boraldi F; Quaglino D; Croce MA; Garcia Fernandez MI; Tiozzo R; Gheduzzi D; Bacchelli B; Pasquali Ronchetti I
Matrix Biol; 2003 Nov; 22(6):491-500. PubMed ID: 14667841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
